Boothbay Fund Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Boothbay Fund Management’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,493	Closed	-$11K	–	2784
2022 Q1	$11K	Hold	1,493	–	–	﹤0.01%	2234
2021 Q4	$20K	Sell	1,493 -4,618	-76%	-$76.4K	﹤0.01%	1800
2021 Q3	$141K	Buy	6,111 +1,424	+30%	+$42.4K	﹤0.01%	1715
2021 Q2	$206K	Sell	4,687 -621	-12%	-$34.6K	0.01%	1511
2021 Q1	$385K	Buy	5,308 +2,662	+101%	+$189K	0.01%	1081
2020 Q4	$114K	Buy	+2,646	New	+$119K	﹤0.01%	1172
2019 Q4	–	Sell	-5,080	Closed	-$604K	–	1041
2019 Q3	$604K	Buy	+5,080	New	+$709K	0.06%	420

Other funds holding ORTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Boothbay Fund Management's ORTX Position: Q2 2022 in Review

Boothbay Fund Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q2 2022, closing a stake of 1,493 shares — an estimated $11K sold.

Boothbay Fund Management first reported a position in ORTX in Q3 2019 and held it in 7 quarters. The position peaked at $604K in Q3 2019. 50 funds tracked by Wall St. Rank hold ORTX as of Q2 2022.

Boothbay Fund Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q2 2022 after selling out during the quarter.
Boothbay Fund Management sold 1,493 Orchard Therapeutics plc American Depositary Shares shares in Q2 2022, an estimated $11K.
Boothbay Fund Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q3 2019 and held it in 7 quarters.
Boothbay Fund Management's Orchard Therapeutics plc American Depositary Shares position peaked at $604K in Q3 2019.
50 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q2 2022.

Based on Boothbay Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.